Cargando…
Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist
BACKGROUND: Interleukin-17A (IL17A) is a proinflammatory cytokine critically involved in autoimmune diseases, and monoclonal antibodies of IL17A have been approved for clinical treatment of psoriasis. However, a usable psoriatic animal model has been always required for preclinical evaluation of IL1...
Autores principales: | Li, Qingran, Liu, Weiping, Gao, Shidong, Mao, Yao, Xin, Yanfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844923/ https://www.ncbi.nlm.nih.gov/pubmed/33509093 http://dx.doi.org/10.1186/s12865-021-00401-3 |
Ejemplares similares
-
Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33
por: Athari, Sara Khaleghparast, et al.
Publicado: (2016) -
Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis
por: Yoshida, Mai, et al.
Publicado: (2023) -
Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A–Producing γδ T Cells
por: Zhang, Song, et al.
Publicado: (2021) -
Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients
por: Yen, Ling-Jung, et al.
Publicado: (2022) -
Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis
por: Niu, Xue-Li, et al.
Publicado: (2019)